Statins As a Novel Therapeutic Strategy in Acute Lung Injury

Overview

Journal Pulm Circ

Publisher Wiley

Specialty Pulmonary Medicine

Date 2013 Feb 2

PMID 23372924

Citations 14

Authors

Sunit Singla

Jeffrey R Jacobson

Affiliations

Soon will be listed here.

Abstract

Acute lung injury (ALI) is a devastating clinical condition associated with pulmonary and systemic inflammation and characterized by incompetence of the pulmonary microvascular barrier culminating in noncardiogenic pulmonary edema. An understanding of the mechanisms underlying endothelial barrier dysfunction in ALI has been facilitated by study of the effects of statins in relevant cellular and animals models. Many of the pleotropic properties of these drugs, including direct effects on endothelial cell (EC) cytoskeletal rearrangement, NADPH oxidase, and nitric oxide activity, as well as effects on differential EC gene expression, are relevant to the pathobiology of ALI and suggest a potential therapeutic role for statins in this context. Moreover, results from preclinical studies and observations in relevant patient populations support the protective potential of statins in ALI, paving the way now for definitive clinical trials.

Citing Articles

The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis.

Vahedian-Azimi A, Mannarino M, Shojaie S, Rahimibashar F, Galeh H, Banach M Arch Med Sci. 2022; 18(6):1513-1524.

PMID: 36457966 PMC: 9710257. DOI: 10.5114/aoms/149633.

Potential biomarkers for inflammatory response in acute lung injury.

Zheng L, Zhang Z, Song K, Xu X, Tong Y, Wei J Open Med (Wars). 2022; 17(1):1066-1076.

PMID: 35795000 PMC: 9186513. DOI: 10.1515/med-2022-0491.

Amelioration of Endotoxin-Induced Acute Lung Injury and Alveolar Epithelial Cells Apoptosis by Simvastatin Is Associated with Up-Regulation of Survivin/NF-kB/p65 Pathway.

Nezic L, Amidzic L, Skrbic R, Gajanin R, Mandic D, Dumanovic J Int J Mol Sci. 2022; 23(5).

PMID: 35269738 PMC: 8910433. DOI: 10.3390/ijms23052596.

Salidroside Protects Against Influenza A Virus-Induced Acute Lung Injury in Mice.

Lu R, Wu Y, Guo H, Zhang Z, He Y Dose Response. 2021; 19(2):15593258211011335.

PMID: 34017230 PMC: 8114266. DOI: 10.1177/15593258211011335.

Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases.

Yang C, Yang C J Inflamm Res. 2021; 14:657-687.

PMID: 33707963 PMC: 7940992. DOI: 10.2147/JIR.S293135.

References

Chen W, Garcia J, Jacobson J . Integrin beta4 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses. J Cell Biochem. 2010; 110(3):718-24. PMC: 2879705. DOI: 10.1002/jcb.22582. View

Liu P, Liu Y, Lin L, Chen J, Liao J . Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2008; 119(1):131-8. PMC: 2745913. DOI: 10.1161/CIRCULATIONAHA.108.813311. View

. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344(8934):1383-9. View

Garcia J, Schaphorst K . Regulation of endothelial cell gap formation and paracellular permeability. J Investig Med. 1995; 43(2):117-26. View

Buhaescu I, Izzedine H . Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007; 40(9-10):575-84. DOI: 10.1016/j.clinbiochem.2007.03.016. View

Fay W, Garg N, Sunkar M . Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol. 2007; 27(6):1231-7. DOI: 10.1161/ATVBAHA.107.140046. View

Craig T, Duffy M, Shyamsundar M, McDowell C, OKane C, Elborn J . A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2010; 183(5):620-6. DOI: 10.1164/rccm.201003-0423OC. View

Polunovsky V, Chen B, Henke C, Snover D, Wendt C, Ingbar D . Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest. 1993; 92(1):388-97. PMC: 293623. DOI: 10.1172/JCI116578. View

Shasby D, Shasby S, Sullivan J, Peach M . Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res. 1982; 51(5):657-61. DOI: 10.1161/01.res.51.5.657. View

10.

Li J, Shah A . Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc Res. 2001; 52(3):477-86. DOI: 10.1016/s0008-6363(01)00407-2. View

11.

Blum A, Shamburek R . The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2008; 203(2):325-30. DOI: 10.1016/j.atherosclerosis.2008.08.022. View

12.

Bogatcheva N, Birukova A, Borbiev T, Kolosova I, Liu F, Garcia J . Caldesmon is a cytoskeletal target for PKC in endothelium. J Cell Biochem. 2006; 99(6):1593-605. DOI: 10.1002/jcb.20823. View

13.

Jones S, ODonnell V, Wood J, Broughton J, Hughes E, Jones O . Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 1996; 271(4 Pt 2):H1626-34. DOI: 10.1152/ajpheart.1996.271.4.H1626. View

14.

Bourcier T, Libby P . HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 2000; 20(2):556-62. DOI: 10.1161/01.atv.20.2.556. View

15.

Laufs U, La Fata V, Plutzky J, Liao J . Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998; 97(12):1129-35. DOI: 10.1161/01.cir.97.12.1129. View

16.

Giancotti F, Tarone G . Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003; 19:173-206. DOI: 10.1146/annurev.cellbio.19.031103.133334. View

17.

Dimmeler S, Brinkmann S, Neugebauer E . Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur J Pharmacol. 1995; 287(3):257-61. DOI: 10.1016/0014-2999(95)00499-8. View

18.

Su G, Hodnett M, Wu N, Atakilit A, Kosinski C, Godzich M . Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function. Am J Respir Cell Mol Biol. 2006; 36(3):377-86. PMC: 1899321. DOI: 10.1165/rcmb.2006-0238OC. View

19.

Wang D, Hirase T, Inoue T, Node K . Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells. Biochem Biophys Res Commun. 2006; 347(2):394-400. DOI: 10.1016/j.bbrc.2006.06.084. View

20.

Endo A, Kuroda M, Tsujita Y . ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo). 1976; 29(12):1346-8. DOI: 10.7164/antibiotics.29.1346. View